Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024)
Spyre Therapeutics (SYRE) posted Exchange Rate Effect of -$15000.0 for Q4 2024, down 193.75% on a QoQ basis from $16000.0 in Q3 2024, and down 183.33% year-over-year from $18000.0 in Q1 2024.
Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024) Analysis & Trends
Spyre Therapeutics' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$15000.0 for Q4 2024.
- Quarterly Exchange Rate Effect fell 183.33% year-over-year to -$15000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$15000.0 (down 150.0% YoY) and the FY2024 annual result came in at -$3000.0, down 112.0% from the prior year.
- Exchange Rate Effect was -$15000.0 for Q4 2024 at Spyre Therapeutics, down from $16000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $47000.0 in Q4 2020 and bottomed at -$72000.0 in Q2 2022.
- A 5-year average of -$3250.0 and a median of $3500.0 in 2021 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 1433.33% in 2022, while the deepest fall reached 1900.0% in 2022.
- Spyre Therapeutics' Exchange Rate Effect stood at $47000.0 in 2020, then plunged by 93.62% to $3000.0 in 2021, then jumped by 1433.33% to $46000.0 in 2022, then slumped by 60.87% to $18000.0 in 2023, then sank by 183.33% to -$15000.0 in 2024.
- Business Quant data shows SYRE's Exchange Rate Effect at -$15000.0 in Q4 2024, $16000.0 in Q3 2024, and -$4000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -72,000.00 |
| Jun 30, 2022 | -72,000.00 |